BERLIN – BioNTech, a German biotechnology firm, has applied for the approval of a potential vaccine for coronavirus disease 2019 (Covid-19) by the European Medicines
BERLIN – BioNTech, a German biotechnology firm, has applied for the approval of a potential vaccine for coronavirus disease 2019 (Covid-19) by the European Medicines